SK Life Science, Inc. is proud to be sponsoring The Danny Did Foundation Giving Tuesday on December 3 in an effort to advance epilepsy and SUDEP awareness and education and to provide seizure detecting devices to families in need. Learn more here: https://lnkd.in/gv-UXRAh.
SK Life Science, Inc.
制药业
Paramus,New Jersey 12,261 位关注者
We believe there is more to life when you connect health with happiness.
关于我们
SK Life Science, Inc., a U.S. subsidiary of SK Biopharmaceuticals, is committed to accelerating the development of innovative treatments for central nervous system (CNS) disorders and oncology. Both companies are a part of SK Group, one of the largest conglomerates in Korea, a global leader in energy, chemical, semiconductor and telecommunications industries, and one of TIME’s 100 Most Influential Companies of 2023. SK Life Science, Inc., is headquartered in Paramus, New Jersey. SK Life Science and SK Biopharmaceuticals have eight compounds in development globally for the treatment of CNS disorders including epilepsy, attention-deficit hyperactivity disorder, schizophrenia, bipolar disorder, and oncology among others. For more information, please visit https://www.sklifescienceinc.com/innovation/#/pipeline. View our community guidelines here: bit.ly/447WI1A
- 网站
-
https://www.sklifescienceinc.com/
SK Life Science, Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Paramus,New Jersey
- 类型
- 私人持股
- 创立
- 2002
- 领域
- CNS、Research、Oncology和Innovation
地点
-
主要
461 From Rd
US,New Jersey,Paramus,07652
SK Life Science, Inc.员工
动态
-
SK Life Science, Inc. is proud to be sponsoring the 2024 PAME Family Day and Conference hosted by Partners Against Epilepsy Mortality (PAME). The PAME Conference (12/5) will bring together advocates and families affected by epilepsy related deaths, to gather in support of raising awareness, education, and prevention of epilepsy-related mortality. The PAME Family Day (12/4) is designed to support bereaved members through building community, providing education, and identifying engagement opportunities. Bereaved adults, professionals, and advocates are welcome as we hear from those who have researched, studied, or experienced loss in their own lives.
-
Join us at #AES2024 for an expert-led symposium on prioritizing seizure treatments through real-world patient case studies. SK Life Science Inc.’s Symposium taking place on 12/6 at 6pm PST will discuss: 👉 Understanding the unmet need for achieving seizure freedom and identifying patients who may need treatment modifications 👉 The impact of continued seizures on patients and their treatment journeys 👉 How treatment regimens may be optimized to provide early efficacy, increase the likelihood of seizure freedom, and decrease the number of concomitant medications
-
-
At SK Life Science, Inc., we are committed to fulfilling the promise of our current treatments and dedicated to finding new ones that will address the needs of those living with a CNS disorder. Learn about our latest data being presented at #AES2024: https://lnkd.in/eptW7atU
-
-
We are officially two weeks away from #AES2024! On 12/6, we will be hosting an expert-led symposium, "Prioritizing Seizure Treatments Through Real-World Patient Case Studies." We are excited to be presenting data highlighting the potential to treat epilepsy in patients with a range of seizure types. We hope to see you there! Visit us at Booth #1303 and pre-register: https://lnkd.in/gu7kCr_J.
-
-
Do you know someone who is: 👉 Suffering from primary generalized tonic-clonic (PGTC) seizures? 👉 Continuing to have PGTC seizures despite taking traditional medications? 👉 Between the ages of 12 and 17? SK Life Science, Inc. is conducting a Phase 3 global randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of an investigational medicine for the treatment of PGTC seizures for patients ages 12 to 17 years old. For more information about the PGTC seizures clinical trial and active trial sites, please see our recent press release: https://lnkd.in/eptW7atU or visit: https://lnkd.in/gQmz5a5q #ClinicalTrials #ClinicalTrialsRecruiting
-
-
This month, we recognize #NationalEpilepsyAwareness Month, a time to raise awareness and support people living with epilepsy. This year the Epilepsy Foundation #NEAM2024 theme is #ShareYourPurplePower, celebrating the unwavering strength, resilience, and courage of epilepsy warriors and their supporters. SK Life Science, Inc. is grateful for the power to shine a light on the incredible strength of the epilepsy community. We are committed to finding new treatments to address the needs of those living with epilepsy. Learn how you can share your Purple Power by visiting: https://lnkd.in/gXkt4mAP? #NEAM #EpilepsyAwareness
National Epilepsy Awareness Month | NEAM
epilepsy.com
-
We are excited to attend Partners Against Epilepsy Mortality (PAME)'s 2024 Conference in Los Angeles on December 5! The keynote speaker at this year’s event is Libby Boyce of the Cameron Boyce Foundation, which is another organization we are proud to partner with. In addition, Family Day will be on December 4. We look forward to raising awareness about people living with epilepsy and we hope to see you there! #EpilepsyAwareness https://lnkd.in/eBbYDyuU
2024 PAME Conference - Partners Against Mortality in Epilepsy
https://pameonline.org
-
We are thrilled to see Joseph McCoy featured as part of SK Group’s #IBelong@SK campaign. Joseph’s statement is a proud reminder that every day, we come together to make a difference in the lives of those we serve, and it’s this shared purpose that drives us forward.
We aim to cultivate a culture of belonging at SK – helping our employees feel empowered and valued each day. Discover what drives this sense of belonging for Joseph McCoy from SK Life Science, Inc. in Paramus, #NewJersey. #IBelongAtSK
-
-
SK Life Science is proud to partner with the Cameron Boyce Foundation, an organization that honors the legacy of Cameron Boyce by aiming to cure epilepsy through funding research, education and awareness campaigns while still supporting causes that were important to Cameron. Through our partnership, we are dedicated to raising awareness for people living with epilepsy. #EpilepsyAwareness #CameronBoyceFoundation https://lnkd.in/gkgFxxU8
The Cameron Boyce Foundation
thecameronboycefoundation.org